Statins given early decrease progression of kidney disease

May 8 2014

Pravastatin, a medicine widely used for treatment of high cholesterol, also slows down the growth of kidney cysts in children and young adults with autosomal dominant polycystic kidney disease (ADPKD), a study has shown. ADPKD is the most common potentially lethal hereditary kidney disease, affecting at least 1 in 1000 people. ADPKD is characterized by progressive kidney enlargement due to cyst growth, which results in loss of kidney function over time.

For more information read the full story here.
 

Recent News

End of shielding - Guidance for clinically extremely vulnerable people - 1st April
April 15 2021
Transplantation restarts at St George’s
April 8 2021
Vaccines -  Information & Education sources for renal patients
January 19 2021
New shielding guidance for clinically extremely vulnerable people - 4th November 2020
November 9 2020
Simon battles through the rain to raise over £2300 as others raise £1000 more
October 5 2020

Join Us

Register with us, become a member and subscribe to our newsletters including the latest on the impact of coronavirus for patients at St George’s Hospital.